Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity
Crossref DOI link: https://doi.org/10.1007/s11030-017-9755-6
Published Online: 2017-06-27
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Jinying
Sang, Zitai
Li, Lu
He, Linhong
Ma, Liang
Funding for this research was provided by:
National Key Programs of China (2012ZX09103101-033)
License valid from 2017-06-27